摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl (4S)-3-(hydroxyamino)-4-methyl-2-oxohexanoate

中文名称
——
中文别名
——
英文名称
tert-butyl (4S)-3-(hydroxyamino)-4-methyl-2-oxohexanoate
英文别名
——
tert-butyl (4S)-3-(hydroxyamino)-4-methyl-2-oxohexanoate化学式
CAS
——
化学式
C11H21NO4
mdl
——
分子量
231.29
InChiKey
RSFREYWGCKSPSA-JAMMHHFISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • AMIDE DERIVATIVES OF ANILINE-RELATED COMPOUNDS AND COMPOSITIONS THEREOF
    申请人:C&C BIOPHARMA, LLC
    公开号:US20150284360A1
    公开(公告)日:2015-10-08
    Amide derivatives of aniline-related compounds are disclosed, including salts thereof, and compositions, preparations and uses thereof. In certain embodiments, the amide derivatives and/or salts thereof show higher solubility in water compared to the corresponding parent aniline-related compounds.
    基苯酰衍生物的衍生物被披露,包括其盐,以及它们的组合物、制剂和用途。在某些实施例中,这些基苯酰衍生物和/或其盐与相应的母体基苯酰相关化合物相比在中显示出更高的溶解度。
  • CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS
    申请人:Hangzhou Dac Biotech Co., Ltd
    公开号:EP3210627A1
    公开(公告)日:2017-08-30
    A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a formula (I), wherein T, L, m, n, Y, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    强效细胞毒剂与细胞表面受体结合分子的共轭物具有式(I),其中 T、L、m、n、Y、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R12 和 R13 在本文中定义,可用于癌症、自身免疫性疾病和传染病的靶向治疗。
  • COMPOSITIONS AND METHODS FOR INCREASING TELOMERASE ACTIVITY
    申请人:HARLEY Calvin Bruce
    公开号:US20140088055A1
    公开(公告)日:2014-03-27
    The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and for enhancing proliferation of stem and progenitor cells.
  • US9403866B2
    申请人:——
    公开号:US9403866B2
    公开(公告)日:2016-08-02
查看更多